Company intelligence / Profile preview
Myopharm
Melbourne, Victoria, Australiamyopharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Myopharm is a clinical-stage Australian biopharmaceutical company developing targeted therapies and consumer health products for chronic metabolic and inflammatory diseases. Its lead candidate, TriGlytza®, targets pro-inflammatory pathways in Type 2 diabetes and has US FDA IND approval covering up to 68 metabolic diseases. The company also markets clinically validated FSMPs generating positive cash flow, with multiple out-license agreements executed in 2023. Clinical trials have been conducted at leading Australian research institutes.
- Therapeutic areas
- EndocrinologyMetabolic Disorders
- Modalities
- Small moleculeFood for Special Medical Purpose (FSMP) products
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Multiple out-license agreements executed in 2023.Academic partnerships with Adelaide University and Baker IDI Heart & Diabetes Institute supporting R&D.
Beyond the preview
Go deeper on Myopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myopharm.